InsidersTradesSigma
유한양행: insider trades · South Korea · DART (FSS)
DART:company-bc1326KR·DART (FSS)Mcap 6235.3Bn€Healthcare
Discover the full directors' dealings record of 유한양행, a listed issuer based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Healthcare sector, 유한양행 has published 27 public disclosures. Market capitalisation: €6,235.3bn. The latest transaction was disclosed on 11 May 2026 — Purchase. Among the most active insiders: 김열홍. Every trade is free.
27
Insider Decl.
0
Thresholds
€195m
27 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
83400.00 €
Analyst consensus
20 analystsBuy
81000.00 €Target 136450.00 €(+64%)180000.00 €
Income statement
Revenue2186.64 Bn€
Gross profit729.92 Bn€33% margin
Net income194.08 Bn€8.9% margin
Valuation
PER (forward)28.3x
Beta0.46
Balance sheet & cash
Market cap6235.33 Bn€
Total debt339.67 Bn€
Free Cash Flow−38.51 Bn€
Debt / Equity15%
Profitability & ownership
ROE8.2%
ROA2.1%
% insiders23.9%
% institutions18.3%
Last declaration on 11 May 2026
Declarations0 total
No declarations found
0 of 0 declarations
About 유한양행
Yuhan Corporation is a South Korean pharmaceutical company engaged in the research, development, and manufacturing of drugs. It is listed on the Korea Exchange, XKRX.